Civic AI
Procurement intelligence
Federal contract award
[26-002079] NHLBI IN-VIVO GENE THERAPY CORE, CAO LAB, AND REMALEY LAB REQUIRES ULTRACENTRIFUGE WHICH WILL BE USED TO SEPARATE, PURIFY, AND ANALYZE VERY SMALL PARTICLES SUCH AS PROTEINS, NUCLEIC ACIDS, VIRUSES, AND CELL ORGANELLES BASED ON THEIR SIZE,
FRANKLIN YOUNG INTERNATIONAL, INCORPORATED · Department of Health and Human Services
- Value
- $79,432
- Start
- Jan 6, 2026
- End
- Apr 6, 2026
- Action date
- Jan 9, 2026
- PIID
- 75N92026F00032
- Status
- completed
- NAICS
- 334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
- Place of performance
- UPLAND, CA
- Award type
- DELIVERY ORDER
Description
[26-002079] NHLBI IN-VIVO GENE THERAPY CORE, CAO LAB, AND REMALEY LAB REQUIRES ULTRACENTRIFUGE WHICH WILL BE USED TO SEPARATE, PURIFY, AND ANALYZE VERY SMALL PARTICLES SUCH AS PROTEINS, NUCLEIC ACIDS, VIRUSES, AND CELL ORGANELLES BASED ON THEIR SIZE,
Need modifications, related awards, and vendor peers? Open the full award workspace.